AngioDynamics Inc
NASDAQ:ANGO
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
5.27
8.04
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one ANGO stock under the Base Case scenario is 6.58 USD. Compared to the current market price of 6.83 USD, AngioDynamics Inc is Overvalued by 4%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
AngioDynamics Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for ANGO cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
AngioDynamics Inc
Balance Sheet Decomposition
AngioDynamics Inc
Current Assets | 172.6m |
Cash & Short-Term Investments | 55m |
Receivables | 39.6m |
Other Current Assets | 78m |
Non-Current Assets | 121m |
PP&E | 39.7m |
Intangibles | 75.8m |
Other Non-Current Assets | 5.6m |
Current Liabilities | 76.7m |
Accounts Payable | 31.3m |
Accrued Liabilities | 30.2m |
Other Current Liabilities | 15.2m |
Non-Current Liabilities | 20.3m |
Other Non-Current Liabilities | 20.3m |
Earnings Waterfall
AngioDynamics Inc
Revenue
|
292.7m
USD
|
Cost of Revenue
|
-141.4m
USD
|
Gross Profit
|
151.4m
USD
|
Operating Expenses
|
-184.8m
USD
|
Operating Income
|
-33.5m
USD
|
Other Expenses
|
-209.6m
USD
|
Net Income
|
-243m
USD
|
Free Cash Flow Analysis
AngioDynamics Inc
USD | |
Free Cash Flow | USD |
In the first quarter of fiscal 2025, AngioDynamics reported revenue of $67.5 million, up 1.1% year-over-year, primarily driven by strong growth in the Med Tech segment, particularly a 24.9% increase from the Auryon platform. Adjusted EBITDA loss narrowed to $200,000 from $1.1 million last year. The company is maintaining its revenue guidance of $282-$288 million for the year, projecting 10-12% Med Tech growth and 1-3% for Med Devices. Significant progress was noted in the rollout of AlphaVac, and a CE mark approval for Auryon opens new opportunities in Europe. The transition to outsourced manufacturing is expected to yield $15 million in cost savings by fiscal 2027.
What is Earnings Call?
ANGO Profitability Score
Profitability Due Diligence
AngioDynamics Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.
Score
AngioDynamics Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.
ANGO Solvency Score
Solvency Due Diligence
AngioDynamics Inc's solvency score is 57/100. The higher the solvency score, the more solvent the company is.
Score
AngioDynamics Inc's solvency score is 57/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ANGO Price Targets Summary
AngioDynamics Inc
According to Wall Street analysts, the average 1-year price target for ANGO is 13.26 USD with a low forecast of 12.12 USD and a high forecast of 14.7 USD.
Dividends
Current shareholder yield for ANGO is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
ANGO Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
AngioDynamics, Inc. is a medical device company, which engages in the development, manufacture, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. The company is headquartered in Latham, New York and currently employs 800 full-time employees. The company went IPO on 2004-05-27. Its devices are used in minimally invasive, image-guided procedures. Its product offerings include Endovascular Therapies, Oncology/Surgery (OS) and Vascular Access (VA). Its Endovascular Therapies product offerings support the medical areas of Thrombus Management, Atherectomy, Peripheral Products (Core) and Venous Insufficiency. Its OS product offerings includes a range of ablation technologies, including thermal tissue ablation systems, surgical resection and the Irreversible Electroporation (IRE) technology, the NanoKnife System. Its portfolio of VA products includes peripherally inserted central catheters (PICCs), midline catheters, implantable ports, dialysis catheters and related accessories and supplies.
Contact
IPO
Employees
Officers
The intrinsic value of one ANGO stock under the Base Case scenario is 6.58 USD.
Compared to the current market price of 6.83 USD, AngioDynamics Inc is Overvalued by 4%.